Literature DB >> 7828260

Anaesthesia for caesarean section in a patient with Watson's syndrome.

J B Conway1, M Posner.   

Abstract

Watson's syndrome is an uncommon genetic disorder whose features include mental retardation and pulmonary valvular stenosis. The purpose of this report is to describe one management strategy used successfully to anaesthetize a woman with this disorder who presented for Caesarean section. Epidural anaesthesia using 0.5% bupivacaine without epinephrine in 2-3 ml boluses to a total dose of 15 ml was administered over 30 min. Invasive haemodynamic monitoring in the form of arterial and central venous catheters were used to guide therapy and help ensure maternal and fetal well-being. Intravenous ketamine in doses of 10-20 mg every five minutes to a total dose of 245 mg (4.5 mg.kg-1) was used to overcome the patient's uncooperative nature and facilitate invasive procedures. Postoperative analgesia was provided using 3 mg epidural morphine. The patient was observed in the intensive care unit for the first postoperative day and experienced an uncomplicated intra- and postoperative course. We conclude that this technique represents a safe and effective method for anaesthetizing patients with this complicated problem for Caesarean section.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7828260     DOI: 10.1007/BF03015663

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  14 in total

1.  Ketamine for obstetric delivery.

Authors:  S Galloon
Journal:  Anesthesiology       Date:  1976-06       Impact factor: 7.892

2.  Prevention of bacterial endocarditis. Recommendations by the American Heart Association.

Authors:  A S Dajani; A L Bisno; K J Chung; D T Durack; M Freed; M A Gerber; A W Karchmer; H D Millard; S Rahimtoola; S T Shulman
Journal:  JAMA       Date:  1990-12-12       Impact factor: 56.272

3.  Anaesthesia for Caesarean section with ketamine.

Authors:  J W Downing; M C Mahomedy; D E Jeal; P J Allen
Journal:  Anaesthesia       Date:  1976-09       Impact factor: 6.955

Review 4.  The fetal and neonatal effects of regional anesthesia in obstetrics.

Authors:  D H Ralston; S M Shnider
Journal:  Anesthesiology       Date:  1978-01       Impact factor: 7.892

5.  Study of ketamine as an obstetric anesthetic agent.

Authors:  B Little; T Chang; L Chucot; W A Dill; L L Enrile; A J Glazko; M Jassani; H Kretchmer; A Y Sweet
Journal:  Am J Obstet Gynecol       Date:  1972-05-15       Impact factor: 8.661

6.  Low-dose ketamine anesthesia for obstetrical delivery.

Authors:  G F Janeczko; A A el-Etr; S Younes
Journal:  Anesth Analg       Date:  1974 Nov-Dec       Impact factor: 5.108

7.  An intravenous method of anaesthesia for Caesarean section. II. Ketamine.

Authors:  F M Meer; J W Downing; A J Coleman
Journal:  Br J Anaesth       Date:  1973-02       Impact factor: 9.166

8.  Pulmonary stenosis, café-au-lait spots, and dull intelligence.

Authors:  G H Watson
Journal:  Arch Dis Child       Date:  1967-06       Impact factor: 3.791

9.  Watson syndrome: is it a subtype of type 1 neurofibromatosis?

Authors:  J E Allanson; M Upadhyaya; G H Watson; M Partington; A MacKenzie; D Lahey; H MacLeod; M Sarfarazi; W Broadhead; P S Harper
Journal:  J Med Genet       Date:  1991-11       Impact factor: 6.318

10.  Effects of ketamine on the pregnant uterus.

Authors:  J N Oats; D P Vasey; B A Waldron
Journal:  Br J Anaesth       Date:  1979-12       Impact factor: 9.166

View more
  1 in total

Review 1.  Specific genetic diseases at risk for sedation/anesthesia complications.

Authors:  M G Butler; B G Hayes; M M Hathaway; M L Begleiter
Journal:  Anesth Analg       Date:  2000-10       Impact factor: 5.108

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.